
    
      The research has carried out in Phase II which is designed as randomized controlled trials.

      Selection of patients began in Feb,2013, 48 patients are divided in two group according to a
      2:1 ratio (the number of candidates as treated: the candidates as control).

      The effectiveness of preliminary trial are evaluated by assessing Frankel/ASIA motor grade,
      measuring electrophysiological parameters, enhanced MRI and urinary and bowel function.
    
  